Fisher & Paykel Healthcare Corporation Ltd

NZ

FPHX

Health Care

26.44 ₽

Current price

Sell
26.44 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    299 / 663

  • Position in country

    131 / 230

  • Return on Assets, %

    11.8

    -11.9

  • Net income margin, %

    13.3

    -12.5

  • EBITDA margin, %

    24.6

    -2.5

  • Debt to Equity, %

    18.4

    15

  • Intangible assets and goodwill, %

    3.5

    3.9

  • Revenue CAGR 3Y, %

    7.7

    12.6

  • Revenue Y, % chg

    11.9

    4.6

  • P/E

    58.4

    28.3

  • P/BV

    8.6

    1.7

  • P/S

    9

    3.7

  • EV/S

    9.1

    3.2

  • EV/EBITDA

    33.8

    -0.2

  • Average Analyst recommendation

    Sell

    Sell

  • Average upside forecasts, %

    -8.8

    66.5

  • Forward P/E

    45.7

    19.2

  • Dividend Yield, %

    2.1

    1.8

  • Forward Dividend Yield, %

    0.9

    0.2

  • Expected dividend per share

    0.2

    0

  • Payout Ratio, %

    52.3

    17.3

  • Dividend Ex Date

    2023-12-05

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Medtronic PLC

    00%

  • Edwards Lifesciences Corp

    00%

  • Siemens Healthineers AG

    00%

  • Abbott Laboratories

    00%

  • Fisher & Paykel Healthcare Corporation Ltd

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    New Zealand

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    9182.9

  • Ticker

    FPH.NZ

  • ISIN

    NZFAPE0001S2

  • IPO date

    2001-11-13

  • Availability on Russian exchanges

    No

  • Reporting for

    2023-11-28

  • Date fact. publication of reports

    2023-09-30

Company Description

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.